Laser Therapy

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Nathan Radcliffe, MD, discusses his experience using a new probe and approach to micropulse transscleral laser therapy for the treatment of glaucoma.

The American Society for Stereotactic and Functional Neurosurgery released a position statement supporting the use of magnetic resonance-guided laser interstitial thermal therapy for patients with drug-resistant epilepsy.

Green thermal laser adjunctive therapy was used to treat resistant infectious keratitis, according to a study.

The portability of retina diagnostic and treatment tools, such as the recently approved Lion green laser system, allows surgeons to provide care for patients in nontraditional settings.

The European Glaucoma Society has accepted MicroPulse transscleral laser therapy into the latest edition of its “Terminology and Guidelines for Glaucoma,” Iridex announced in a press release.

DJO LLC announced it has acquired LiteCure Laser Therapy, a manufacturer of therapeutic laser technology for human and animal health.

Long-term study results of glaucoma implant tube surgery presented at the virtual American Academy of Ophthalmology annual meeting showed posterior tubes were equally effective at lowering intraocular pressure as anterior counterparts and displayed a low rate of erosion.

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, Douglas D. Koch, MD, discusses his study of an automated iris registration algorithm using the Cassini low-light topographer and the Catalys femtosecond laser platform (Johnson & Johnson Vision) for the correction of astigmatism in cataract surgery.

A post hoc analysis of a subset of patients with diabetic macular edema treated with an anti-VEGF agent in the VISTA phase 3 trial identified a moderate correlation between significant reductions in macular retinal nonperfusion with improvements in best corrected visual acuity and central retinal thickness, according to a presenter at the virtual Association for Research in Vision and Ophthalmology meeting.

Data from the ZIPANGU study showed the use of focal/grid short-pulse laser therapy in patients receiving ranibizumab injections for the treatment of macular edema secondary to branch retinal vein occlusion did not reduce the number of necessary injections compared with patients undergoing ranibizumab monotherapy, according to a presenter at the virtual Association for Research in Vision and Ophthalmology meeting.